These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 15352219

  • 1. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
    Sørensen G, Lindberg C, Wörtwein G, Bolwig TG, Woldbye DP.
    J Neurosci Res; 2004 Sep 01; 77(5):723-9. PubMed ID: 15352219
    [Abstract] [Full Text] [Related]

  • 2. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
    Ishida H, Shirayama Y, Iwata M, Katayama S, Yamamoto A, Kawahara R, Nakagome K.
    Hippocampus; 2007 Sep 01; 17(4):271-80. PubMed ID: 17265460
    [Abstract] [Full Text] [Related]

  • 3. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
    Henry M, Ghibaudi L, Gao J, Hwa JJ.
    Obes Res; 2005 Jan 01; 13(1):36-47. PubMed ID: 15761161
    [Abstract] [Full Text] [Related]

  • 4. Tolerance to ethanol sedation and withdrawal hyper-excitability is mediated via neuropeptide Y Y1 and Y5 receptors.
    Bhisikar SM, Kokare DM, Nakhate KT, Chopde CT, Subhedar NK.
    Life Sci; 2009 Nov 18; 85(21-22):765-72. PubMed ID: 19846044
    [Abstract] [Full Text] [Related]

  • 5. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y, Thakur M, Beck-Sickinger A, Fournier A, Quirion R.
    Neuropeptides; 2004 Aug 18; 38(4):163-74. PubMed ID: 15337369
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S, Li DL, Simmons RM.
    J Pharmacol Exp Ther; 1999 May 18; 289(2):1031-40. PubMed ID: 10215684
    [Abstract] [Full Text] [Related]

  • 8. Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
    Goyal SN, Upadhya MA, Kokare DM, Bhisikar SM, Subhedar NK.
    Brain Res; 2009 Apr 17; 1266():45-53. PubMed ID: 19254701
    [Abstract] [Full Text] [Related]

  • 9. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
    Deo GS, Dandekar MP, Upadhya MA, Kokare DM, Subhedar NK.
    Brain Res; 2010 Mar 08; 1318():77-86. PubMed ID: 20059983
    [Abstract] [Full Text] [Related]

  • 10. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A, Rägo L, Harro J.
    Br J Pharmacol; 1998 Aug 08; 124(7):1507-15. PubMed ID: 9723965
    [Abstract] [Full Text] [Related]

  • 11. The selective neuropeptide Y Y5 agonist [cPP(1-7),NPY(19-23),Ala31,Aib32,Gln34]hPP differently modulates emotional processes and body weight in the rat.
    Morales-Medina JC, Dominguez-Lopez S, Gobbi G, Beck-Sickinger AG, Quirion R.
    Behav Brain Res; 2012 Aug 01; 233(2):298-304. PubMed ID: 22613731
    [Abstract] [Full Text] [Related]

  • 12. L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist.
    Kanatani A, Ishihara A, Iwaasa H, Nakamura K, Okamoto O, Hidaka M, Ito J, Fukuroda T, MacNeil DJ, Van der Ploeg LH, Ishii Y, Okabe T, Fukami T, Ihara M.
    Biochem Biophys Res Commun; 2000 May 27; 272(1):169-73. PubMed ID: 10872822
    [Abstract] [Full Text] [Related]

  • 13. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
    Tovote P, Meyer M, Beck-Sickinger AG, von Hörsten S, Ove Ogren S, Spiess J, Stiedl O.
    Regul Pept; 2004 Aug 15; 120(1-3):205-14. PubMed ID: 15177939
    [Abstract] [Full Text] [Related]

  • 14. Y5 neuropeptide Y receptor overexpression in mice neither affects anxiety- and depression-like behaviours nor seizures but confers moderate hyperactivity.
    Olesen MV, Christiansen SH, Gøtzsche CR, Holst B, Kokaia M, Woldbye DP.
    Neuropeptides; 2012 Apr 15; 46(2):71-9. PubMed ID: 22342800
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat.
    Trent NL, Menard JL.
    Pharmacol Biochem Behav; 2011 Oct 15; 99(4):580-90. PubMed ID: 21693128
    [Abstract] [Full Text] [Related]

  • 17. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
    Gehlert DR, Schober DA, Morin M, Berglund MM.
    Biochem Pharmacol; 2007 Dec 03; 74(11):1652-64. PubMed ID: 17897631
    [Abstract] [Full Text] [Related]

  • 18. Effects of neuropeptide Y on food intake and brain biogenic amines in the rainbow trout (Oncorhynchus mykiss).
    Aldegunde M, Mancebo M.
    Peptides; 2006 Apr 03; 27(4):719-27. PubMed ID: 16253390
    [Abstract] [Full Text] [Related]

  • 19. Selective activation of central NPY Y1 vs. Y5 receptor elicits hyperinsulinemia via distinct mechanisms.
    Gao J, Ghibaudi L, Hwa JJ.
    Am J Physiol Endocrinol Metab; 2004 Oct 03; 287(4):E706-11. PubMed ID: 15187000
    [Abstract] [Full Text] [Related]

  • 20. Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption.
    Parrado C, Díaz-Cabiale Z, García-Coronel M, Agnati LF, Coveñas R, Fuxe K, Narváez JA.
    Neuropharmacology; 2007 Feb 03; 52(2):684-92. PubMed ID: 17087983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.